Galmed Pharmaceuticals Ltd. Stock Price and Value Analysis

Should you buy Galmed Pharmaceuticals Ltd. stock? (NasdaqCM:GLMD). Let's see how it does in our automated value investing analysis system.

  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company pays no dividend.

Inside the GLMD Numbers

GLMD Price
(Galmed Pharmaceuticals Ltd. stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Biotechnology stocks
[?] Free Cash Flow Jitter 0%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 18,666 shares shorted. With 19,789,741 shares available for purchase and an average trading volume over the past 10 trading days of 56,980, it would take at least 0.328 days for all of the short holders to cover their shorts.

Is Galmed Pharmaceuticals Ltd. Stock on Sale?

Based on our analysis, we believe that you should not buy Galmed Pharmaceuticals Ltd. right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy GLMD Stock?

Does Galmed Pharmaceuticals Ltd. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.